<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">L</forename><surname>Serre</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Herman Van Tilbeurgh&apos;s Group</orgName>
								<orgName type="department" key="dep2">Institut de Biochimie</orgName>
								<orgName type="department" key="dep3">Equipe Génomique Structurale</orgName>
								<orgName type="laboratory" key="lab1">et de Biophysique Moléculaire et Cellulaire (IBBMC)</orgName>
								<orgName type="laboratory" key="lab2">UMR8619</orgName>
								<orgName type="institution" key="instit1">CNRS</orgName>
								<orgName type="institution" key="instit2">Université Paris-Sud</orgName>
								<address>
									<settlement>Orsay</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jenny</forename><surname>Keller</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Herman Van Tilbeurgh&apos;s Group</orgName>
								<orgName type="department" key="dep2">Institut de Biochimie</orgName>
								<orgName type="department" key="dep3">Equipe Génomique Structurale</orgName>
								<orgName type="laboratory" key="lab1">et de Biophysique Moléculaire et Cellulaire (IBBMC)</orgName>
								<orgName type="laboratory" key="lab2">UMR8619</orgName>
								<orgName type="institution" key="instit1">CNRS</orgName>
								<orgName type="institution" key="instit2">Université Paris-Sud</orgName>
								<address>
									<settlement>Orsay</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">FEDA2470EF065E129585A8F9058DC7F4</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T21:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>30-01-796</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Jenny Keller* (3 shifts) : yeast multi-protein complexes involved in DNA replication, ribosome biogenesis, mRNA quality control pathway and cell signalling and archeophage structural genomics project 1) Virar79 Spacegroup: P6 1 22 with a=b=62 Å and c=111Å Resolution: 2.33 Å. Rsym=0.098 Completion 100%)</p><p>We solved the structure of virar79, a 15kD protein from Acidianus Filamentus virus 1. X-ray diffraction data from a crystal of the SeMet substituted virar79 were collected on beamline BM30A (ESRF) at the Se K-edge. The crystal diffracted to 2.33 Å and belongs to P6 1 22 space group with one molecule per asymmetric unit. From these data, we could obtain high quality experimental phases that allowed us to build the protein. The structure was further refined against 1.9 Å resolution native data collected on the ESRF ID29 beamline. The protein consists in a beta-alpha-beta sandwich. Two anti parallel 4-stranded beta sheets surround 3 alpha helices with a β1β2α1β3β4α2β5β6α3β7β8 topology. One sheet is composed of β1β2β7β8 and the other of β3β4β5β6.The connection between the two sheets is performed by α1 in one side and by α3 in the opposite side (α1 connects β2 to β3 and α3 connects β6 to β7) while α2 connects two strands from the same sheet (β4 to β5). The tree helices establish few hydrophobic contacts between them. The protein is composed of two quasi identical domains related by a two fold symmetry axis. The first domain is comprises β1β2α3β7β8 and the second β3β4α2β5β6α1. An rmsd of 1.34 Å is observed for 29Cα of the two domains. The main difference between the two domains comes from the insertion of 14 residues forming the helix α2 and the linker between α2 and β4.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body/>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Structure of virar79:</head><p>Left: cartoon representation of the protein colored as left. Right: superposition of the two domains.</p></div>			</div>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
